Provided we start getting revenue in in the next two quarters, no CR will be necessary IMO. We have enough cash for approx 3 quarters, so the need for the R&D rebate may not be as high. Would still be better to get it then not, but I can’t see it hurting the company much, if at all.
Also, remember that CAT has a large option outstanding that would further reduce any need for a CR if taken up.
Multimillion dollar shortfall in FBR's R&D funding, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $207.4M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 102800 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 238119 | 1 |
View Market Depth
| Last trade - 16.12pm 01/11/2024 (20 minute delay) ? |
| FBR (ASX) Chart |
Day chart unavailable